相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil
Kelly Champagne et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Mutations in gp120 Contribute to the Resistance of Human Immunodeficiency Virus Type 1 to Membrane-Anchored C-Peptide maC46
Felix G. Hermann et al.
JOURNAL OF VIROLOGY (2009)
Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency
Paolo Ingallinella et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Intravenous anesthetics inhibit human paraoxonase-1 (PON1) activity in vitro and in vivo
Haci Ahmed Alici et al.
CLINICAL BIOCHEMISTRY (2008)
Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor
Yuxian He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Peptide mimic of the HIV envelope gp120-gp41 interface
Saonghwan Kim et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Selection of T1249-resistant human immunodeficiency virus type 1 variants
Dirk Eggink et al.
JOURNAL OF VIROLOGY (2008)
Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: Implications for designing novel anti-HIV fusion inhibitors
Yuxian He et al.
JOURNAL OF VIROLOGY (2008)
Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains
Yuxian He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Potent D-peptide inhibitors of HIV-1 entry
Brett D. Welch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus
John J. Dwyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Exploitation of structural and regulatory diversity in glutamate racemases
Tomas Lundqvist et al.
NATURE (2007)
Kinetic dependence to HIV-1 entry inhibition
H. Kirby Steger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody
Micah A. Luftig et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Characterization of envelope glycoprotein gp41 genotype and phenotypic susceptibility to enfuvirtide at baseline and on treatment in the phase III clinical trials TORO-1 and TORO-2
T. Melby et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors
M Zeghouf et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope
MD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro
M Mink et al.
JOURNAL OF VIROLOGY (2005)
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection
E Bianchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus
EJ Platt et al.
JOURNAL OF VIROLOGY (2005)
The cytoplasmic tail slows the folding of human immunodeficiency virus type 1 Env from a late prebundle configuration into the six-helix bundle
LG Abrahamyan et al.
JOURNAL OF VIROLOGY (2005)
HIV-1 gp41 as a target for viral entry inhibition
MJ Root et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Direct evidence that C-peptide inhibitors of human immunodeficiency virus type 1 entry bind to the gp41 N-helical domain in receptor-activated viral envelope
NR Kilgore et al.
JOURNAL OF VIROLOGY (2003)
HIV-1 resistance to the gp41-dependent fusion inhibitor C-34
M Armand-Ugón et al.
ANTIVIRAL RESEARCH (2003)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
A Lazzarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics
JD Reeves et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region
DM Eckert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Design and properties of NCCG-gp41, a chimeric gp41 molecule with nanomolar HIV fusion inhibitory activity
JM Louis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Protein design of an HIV-1 entry inhibitor
MJ Root et al.
SCIENCE (2001)
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
GB Melikyan et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
